BSF Enterprise Plc (LON:BSFA)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.9560
-0.0940 (-8.95%)
Nov 6, 2026, 4:07 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 1.83 million as of November 6, 2026. It is the 47,343rd most valuable company in the world and the 1,075th biggest in the United Kingdom. Its market cap has decreased by 54.65% in one year.
Market Cap
1.83M
Enterprise Value
2.56M
Revenue
51.07K
Global Rank
Country Rank
#1,075 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.02M to 1.83M, an increase of 80.34%. That is a compound annual growth rate of 8.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.92M | -21.35% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.34% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 7.20M |
| CRISM Therapeutics | 6.93M |
| Solvonis Therapeutics | 6.81M |
| Palatin Technologies | 6.77M |
| OptiBiotix Health | 5.78M |
| Cizzle Biotechnology Holdings | 4.89M |
| Theracryf | 4.64M |
| Futura Medical | 2.80M |